My wife was on the brand when it first came out for a few months, I think maybe less than a year and fell 2 times. It was decided it wasn't working for her so she stopped and switched to something else. But it worked for a few months as best as we know. It was a long time ago.
September 19, 2022
For Relapsing-Remitting Multiple Sclerosis (RRMS), several disease-modifying treatments (DMTs) are available. Here are some options:
Oral Medications
- Dimethyl fumarate (Tecfidera): Twice a day
- Diroximel fumarate (Vumerity): Twice a day
- Monomethyl fumarate (Bafiertam): Twice a day
- Ozanimod (Zeposia): Once a day
- Show Full Answer
For Relapsing-Remitting Multiple Sclerosis (RRMS), several disease-modifying treatments (DMTs) are available. Here are some options:
Oral Medications
- Dimethyl fumarate (Tecfidera): Twice a day
- Diroximel fumarate (Vumerity): Twice a day
- Monomethyl fumarate (Bafiertam): Twice a day
- Ozanimod (Zeposia): Once a day
- Cladribine (Mavenclad): 10 pills in year one, 10 pills in year two
- Teriflunomide (Aubagio): Once a day
- Ponesimod (Ponvory): Once a day
- Siponimod (Mayzent): Once a day
Injectable Medications
- Glatiramer acetate (Copaxone): Daily or three times a week
- Interferon beta-1a (Avonex): Once a week
- Interferon beta-1a (Rebif): Three times a week
- Interferon beta-1b (Betaseron): Every other day
- Interferon beta-1b (Extavia): Every other day
- Peginterferon beta-1a (Plegridy): Every two weeks
- Ofatumumab (Kesimpta): Monthly
IV Infusions
- Natalizumab (Tysabri): Monthly
- Ocrelizumab (Ocrevus): Every six months
- Alemtuzumab (Lemtrada): Five days in a row, then three days one year later
- Ublituximab (Briumvi): 2.5-hour IV infusion every six months
Additional Information
- Corticosteroids: Used for acute relapses to control symptoms and inflammation. Examples include Solu-Medrol (methylprednisolone) and Acthar Gel.
Considerations
- The choice of DMT should be based on individual needs and symptoms, with guidance from a healthcare provider.
- Factors such as the method of administration and dosage schedule can influence the decision.
For more detailed discussions, consider consulting with a neurologist or joining support networks like MyMSTeam.
July 11, 2024